Article Sidebar

PDF
Date Published: 07/08/2023
Abstract Views: 440
Views PDF: 148
DOI: https://doi.org/10.51298/vmj.v528i2.6100
Issue
Vol. 528 No. 2 (2023)
Section
Các bài báo
How to Cite
Lê, Q. T. (2023). SITUATION OF ELECTROLYTE DISORDERS IN CIRRHOSIS PATIENTS TREATED AT THANH BA DISTRICT MEDICAL CENTER. Vietnam Medical Journal, 528(2). https://doi.org/10.51298/vmj.v528i2.6100

SITUATION OF ELECTROLYTE DISORDERS IN CIRRHOSIS PATIENTS TREATED AT THANH BA DISTRICT MEDICAL CENTER

Quốc Tuấn Lê1,
1 Thanh Ba District Medical Center

Main Article Content

Abstract

Aims: To study electrolyte disorders in cirrhosis patients at Thanh Ba District Medical Center. Subjects and Methods: A prospective cross-sectional descriptive study on 53 cirrhotic patients at Thanh Ba District Medical Center from February 2021 to December 2022. Results: The mean age in the study group was 53.7 years old. Male accounted for 90.6%, female accounted for 9.4%. Hyponatremia accounted for 47.2%, and hypokalemia accounted for 43.4%, and hyperkalemia accounted for 5.7%. There was no association between electrolyte disorders and severity of cirrhosis and complications of cirrhosis. However, there were 2 deaths with hyponatremia, and 3 deaths with hyperkalemia.

Article Details

Keywords

Cirrhosis, electrolyte disorders, sodium, potassium

References

Nguyễn Thị Vân Hồng (2008), Xơ gan, Sổ Tay Tiêu Hóa Thực Hành, Tập 1.Nhà Xuất Bản Y Học.tr 73 – 80.
2. Nguyễn Xuân Huyên (2000), Xơ Gan, Bách khoa thư bệnh học, Tập 3. Nhà Xuất Bản Từ Điển Bách khoa.tr 549-552.
3. Bùi Quang Thạch (2008), Bước đầu đánh giá hiệu quả lợi tiểu của Spironolactone và Furocemide để điều trị cổ trướng ở bệnh nhân xơ gan, Luận văn tốt nghiệp bác sỹ nội trú, Đại Học Y Hà Nội.
4. F Salerno, A Gerbes, P Gines et al. (2007), "Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis", The International Ascites Club - GUT 2007. 56: p. 1310 – 1318.
5. G. Borroni, A. Maggi, A. Sangiovanni et al. (2000), "Clinical relevance of hyponatremia for the hospital outcome of cirrhosis patients", Dig Liver Dis. 10: p. 605.
6. Jun-Jun Cai (2019). “Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients”, Biomed Res Int 2019 Feb 27;2019:60.
7. M Kaplan (2018). “Prognostic Utility of Hypokalemia in Cirrhotic Patients”, Acta Gastroenterol Belg, Jul-Sep 2018;81(3):398-403.
8. Angeli P, Wong F, Watson H, et al (2006). Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology 2006;44:1535‑42.
9. Devrajani BR, Shah SZ, Devrajani T, Kumar D (2006). Precipitating factors of hepatic encephalopathy at a tertiary care hospital Jamshoro, Hyderabad. JPMA. J Pak Med Assoc 2009;59:683.
10. Sersté T, Gustot T, Rautou PE, et al (2012). Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol 2012;57:274‑80